Alan Steele has over a dozen years of experience in Intellectual Property and centers his practice around the preparation and prosecution of domestic and foreign patent applications in the fields of biotechnology, immunology, chemistry, nucleic acids, antibodies, pharmaceuticals, vaccines, therapeutics, molecular diagnostics and medical devices. His practice includes advising clients in strategic patent portfolio development and management, as well as the preparation of patentability, non-infringement, patent invalidity and patent clearance opinions. Mr. Steele’s clients include leading hospitals and academic institutions, start-up companies, well-established small companies and large pharmaceutical companies.

Mr. Steele has experience in due diligence studies for patent portfolio licensing and acquisition transactions, trade secrets and litigation support, including responding to a request to initiate march-in proceedings under the Bayh-Dole Act.

Before practicing law, Mr. Steele practiced medicine as an academic internist for thirteen years and was board certified in internal medicine and nephrology. He worked as an instructor in medicine at Harvard Medical School and an assistant professor of medicine at the University of Massachusetts Medical School. At Harvard and at the University of Massachusetts he conducted independent basic research investigating fundamentals of T-cell and transplantation biology, with a special interest in translational research. He has hands-on clinical and technical experience in molecular and cellular biology, monoclonal antibodies, transplantation, hemodialysis and peritoneal dialysis.